Educational Guide

What Is Synapsin?

A neutral, research-backed overview of Synapsin — its mechanism of action, published evidence, and current safety profile. This guide is designed for educational purposes and does not constitute medical advice.

1 cited studies
Updated: 2026-05-13
Nootropic Peptide

EDUCATIONAL USE ONLY: ⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Overview

Synapsin is classified as a nootropic peptide peptide. Cognitive enhancement, neuroprotection, mitochondrial function, synaptic plasticity.

Compounded intranasal formulation (not a single peptide) combining Rg3 (ginsenoside), NAD+, and additional neuroprotective compounds. Rg3 modulates NMDA and GABA receptor activity, reduces neuroinflammation via NF-kB inhibition, and promotes BDNF expression. NAD+ component supports mitochondrial function and sirtuin activation. Intranasal delivery bypasses blood-brain barrier. Often used in TBI, post-COVID cognitive impairment, and neurodegenerative disease support protocols.

Also known as: Intranasal Synapsin, RG3 + NAD+ compound

Category

Nootropic Peptide

Route

Nasal

FDA Status

Not Approved

How Does Synapsin Work?

Compounded intranasal formulation (not a single peptide) combining Rg3 (ginsenoside), NAD+, and additional neuroprotective compounds. Rg3 modulates NMDA and GABA receptor activity, reduces neuroinflammation via NF-kB inhibition, and promotes BDNF expression. NAD+ component supports mitochondrial function and sirtuin activation. Intranasal delivery bypasses blood-brain barrier. Often used in TBI, post-COVID cognitive impairment, and neurodegenerative disease support protocols.

At the molecular level, Synapsin operates through pathways characteristic of the Nootropic Peptide class, interacting with target receptors and downstream signaling cascades to produce its observed effects.

Published Research

The following studies are indexed from PubMed and peer-reviewed journals:

Safety Profile

Research only. Compounded intranasal formulation — individual components (Rg3, NAD+) have some published safety data but the specific compound blend lacks clinical trial validation. Not FDA-approved. Used in functional medicine under practitioner supervision.

Side EffectIncidenceSeverity
Nasal irritation~10%mild
Mild headache~5%mild

Sourcing Synapsin for Research

If you're looking to source Synapsin for laboratory research, our vendor directory compares pricing, purity testing, and COA verification from independently vetted suppliers.

Disclosure: PeptiDex may earn a commission from affiliate links. This does not affect our recommendations.

Full Research Profile

Synapsin — dosing, interactions, timelines & more

Comprehensive compound profile with sourcing information, stacking synergies, and outcome timelines.

Related Educational Guides

Educational Content Disclaimer

This guide is provided for educational and research purposes only. Nothing on this page should be interpreted as medical advice. Always consult a licensed healthcare professional. Read our full disclaimer.

Last updated: 2026-05-13 · Educational Hub · Editorial Standards